[HTML][HTML] Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression

K Ando, F Küçükali, E Doeraene, S Nagaraj… - Acta …, 2024 - Springer
A recent large genome-wide association study has identified EGFR (encoding the epidermal
growth factor EGFR) as a new genetic risk factor for late-onset AD. SHIP2, encoded by …

The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta‐mediated pathology

JD Samuels, KA Moore, HE Ennerfelt… - Alzheimer's & …, 2023 - Wiley Online Library
Abstract Introduction Mutations in INPP5D, which encodes for the SH2‐domain‐containing
inositol phosphatase SHIP‐1, have recently been linked to an increased risk of developing …

[HTML][HTML] INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia

AP Tsai, PBC Lin, C Dong, M Moutinho, BT Casali… - Neurobiology of …, 2021 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, robust microgliosis, neuroinflammation, and neuronal loss. Genome-wide …

[HTML][HTML] INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology

EO Olufunmilayo, RMD Holsinger - Genes, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia, accounting for
approximately 38.5 million cases of all-cause dementia. Over 60% of these individuals live …

SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease

CD Jesudason, ER Mason, S Chu… - … Research & Clinical …, 2023 - Wiley Online Library
INTRODUCTION The risk of developing Alzheimer's disease is associated with genes
involved in microglial function. Inositol polyphosphate‐5‐phosphatase (INPP5D), which …

A target enablement package for the inhibition of SHIP1 as a therapeutic strategy for the treatment of Alzheimer's disease

TI Richardson, CD Jesudason, KL Lobb… - Alzheimer's & …, 2022 - Wiley Online Library
Background Recent evidence including GWAS and differential gene expression comparing
normal to affected Alzheimer's brain tissue have identified risk and protective variants in …

Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease

P Nowotny, S Bertelsen, AL Hinrichs, JSK Kauwe… - Neuroscience …, 2007 - Elsevier
Alzheimer's disease (AD) pathology is associated with two proteins, the microtubule-binding
protein tau and the β-amyloid-precursor protein (APP). When tau becomes …

A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease

SL Ma, NLS Tang, CWC Tam, VWC Lui, LCW Lam… - Neurobiology of …, 2012 - Elsevier
Alzheimer's disease (AD), the most common form of dementia, is characterized by the
presence of neurofibrillary tangles composed of tau and senile plaques of amyloid-beta …

[HTML][HTML] PIN1 gene variants in Alzheimer's disease

A Maruszak, K Safranow, K Gustaw… - BMC medical …, 2009 - Springer
Background Peptidyl-prolyl isomerase, NIMA-interacting 1 (PIN1) plays a significant role in
the brain and is implicated in numerous cellular processes related to Alzheimer's disease …

PIN1 promoter polymorphisms are associated with Alzheimer's disease

L Segat, A Pontillo, G Annoni, D Trabattoni… - Neurobiology of …, 2007 - Elsevier
In our study, we analyzed the coding and promoter regions of the PIN1 gene in a group of
111 Alzheimer's disease (AD) patients looking for a possible genotype–phenotype …